Lemaitre Vascular (LMAT) FY2017 results: revenue $101 million, up 13.1% on the year
Lemaitre Vascular Inc. (LMAT) reported revenue of $101 million for fiscal 2017, the year ended 31 December 2017, up 13.1% on the year before. Net income was $17 million, up 62.2%, and diluted earnings per share $0.86. The figures are the company's own, from the 10-K it filed with the SEC on 11 March 2019.
Revenue
$101 million
+13.1% on the year
FY2010FY2017
Operating margin
20.9%
18.3% a year earlier
FY2010FY2017
Net income
$17 million
+62.2% on the year
FY2010FY2017
Diluted EPS
$0.86
+56.4% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
101
89.2
78.4
+13.1%
Cost of revenue
30.2
26.2
24.2
+15.1%
Gross profit
70.7
62.9
54.2
+12.3%
Gross margin
70.1%
70.6%
69.1%
Research and development
6.6
6.1
5.5
+8.1%
Operating income
21.1
16.3
11.5
+29.2%
Operating margin
20.9%
18.3%
14.7%
Interest expense
0.0
0.0
n/a
+50.0%
Pre-tax income
21.1
16.2
11.4
+29.9%
Income tax
3.9
5.7
3.7
-30.5%
Effective tax rate
18.6%
34.8%
32.1%
Net income
17.2
10.6
7.8
+62.2%
Net margin
17.0%
11.9%
9.9%
Diluted EPS
$0.86
$0.55
$0.42
+56.4%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
22.9
16.9
11.4
+35.3%
Capital expenditure
6.4
2.8
2.3
+125.9%
Free cash flow
16.5
14.1
9.2
+17.0%
Free cash flow margin
16.3%
15.8%
11.7%
Cash from investing
-29.0
-17.2
n/a
Cash from financing
0.1
-2.6
n/a
Depreciation and amortisation
4.1
3.6
3.4
+12.9%
Share-based compensation
2.3
1.7
1.4
+34.3%
Buybacks
0.8
0.3
0.3
+150.2%
Dividends paid
4.2
3.3
2.8
+25.8%
Dividend per share
$0.22
$0.18
$0.16
+22.2%
Diluted shares, weighted
20m
19m
18m
+4.1%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
110
87.5
77.9
+25.5%
Debt
0.0
0.0
0.0
Other liabilities
16.6
14.4
12.8
+14.8%
Total liabilities and equity
126
102
90.7
+23.9%
Fixed assets
12.4
8.0
7.0
+54.5%
Goodwill
23.8
23.4
17.8
+1.8%
Intangible assets
8.2
9.9
6.3
-16.8%
Investments
22.6
n/a
n/a
Cash and equivalents
19.1
24.3
27.5
-21.4%
Receivables
15.0
13.2
12.0
+13.7%
Inventory
n/a
19.6
15.2
Other assets
25.2
3.5
4.9
+613.7%
Total assets
126
102
90.7
+23.9%
10-K for the year ended 31 December 2017, filed 11 March 2019: the filing.